Details of Drug-Drug Interaction
| Drug General Information (ID: DDI7W4GZUD) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Indium In-111 oxyquinoline | Drug Info | Delafloxacin | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Diagnostic Radiopharmaceuticals | Quinolones/Antibiotics | |||||||
| Structure | |||||||||
| Mechanism of Indium In-111 oxyquinoline-Delafloxacin Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Attenuated pharmacological effects (Unspecific) Click to Show/Hide Mechanism Graph | |||||||||
| Drug Name | Indium In-111 oxyquinoline | Delafloxacin | |||||||
| Mechanism | Indium In-111 oxyquinoline | Cause false-negative results with Indium In-111-labeled leukocyte studies | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Pharmacodynamics | ||||||||
| Factor Description | Reduced pharmacological effects leading to insufficient efficacy and/or treatment failure. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Clinicians should be aware of possible diagnostic interference in patients who are on long-term antibiotic treatment, corticosteroids, interleukin-2, parenteral nutrition, or high doses or supratherapeutic concentrations of lidocaine or procainamide. | ||||||||
| References | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Product Information. Indium Oxyquinoline In-111 (indium oxyquinoline In-111). GE Healthcare, Princeton, NJ. | ||||||||||||||||||
